FOXM1-RHNO1 cooperatively promoted high-grade serous ovarian cancer (HGSC) cell growth, and knockdown of the two genes sensitized HGSC cells to the PARPi olaparib and mitigates acquired olaparib resistance (Barger et al., 2019). The gene discussed is RHNO1; the disease is ovarian serous adenocarcinoma.